Novaya klassifikatsiya khronicheskoy obstruktivnoy bolezni legkikh: novye vozmozhnosti ili novye problemy?
- Authors: Zykov K.A1, Sokolov E.I2
-
Affiliations:
- НИМСИ
- ГБОУ ВПО МГМСУ им. А.И.Евдокимова Минздрава РФ
- Issue: Vol 15, No 5 (2013)
- Pages: 42-47
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/93849
- ID: 93849
Cite item
Full Text
Abstract
Как известно, хроническая обструктивная болезнь легких (ХОБЛ) относится к числу наиболее распространенных заболеваний человека.Важность проблемы ХОБЛ для современной медицины сложно переоценить. Именно поэтому столь значительное внимание уделяется новым рекомендательным документам по диагностике и лечению ХОБЛ, с которыми связывают надежды на улучшение качества ведения данных пациентов.
Full Text
##article.viewOnOriginalSite##About the authors
K. A Zykov
НИМСИЛаборатория пульмонологии
E. I Sokolov
ГБОУ ВПО МГМСУ им. А.И.Евдокимова Минздрава РФКафедра факультетской терапии и профболезней
References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic pulmonary disease, 2001. http://www.goldcopd.org/Guidelines/guidelines-resources.html
- Vanfleteren L.E, Franssen F.M, Wesseling G, Wouters E.F. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands. Respir Med 2012; 106 (6): 871–4.
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. Available from: http://www.goldcopd.org/
- Российский статистический ежегодник. М., 2011. http://www.gks.ru/bgd/regl/b11_34/IssWWW.exe/Stg/d01/01-01.htm
- World Health Organization 2011 Reprinted 2011 WHO Library Cataloguing - in - Publication Data Global status report on noncommunicable diseases 2010.
- Murray C.J, Lopez A.D. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349: 1498–504.
- NMH/MND/CPM/13.1 Global alliance against chronic respiratory diseases (GARD) 7th General Meeting, 9–10 July 2012, St. Petersburg, Russia http://www.who.int/gard/publications/GARDGMReportStPetersburg2012.pdf
- Клинические рекомендации. Хроническая обструктивная болезнь легких. 2-е изд., испр. и доп. Под ред. А.Г. Чучалина, М.: ИД «Атмосфера», 2007.
- Vestbo J, Hurd S.S, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) – why and what? Clin Respir J 2012; 6: 208–14.
- Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645–8.
- Vestbo J, Edwards L, Scanlon P et al. Changes in Forced Expiratory Volume in 1 Second over Time in COPD. N Engl J Med 2011; 365: 1184–92.
- Agusti A, Calverley P, Celli B et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122–36.
- From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006. Available from: http://www.goldcopd.org/
- Gruffydd-Jones K. GOLD guidelines 2011: what are the implications for primary care? Prim Care Respir J 2012; 21 (4): 437–41.
- Jones P.W. Health status and the spiral of decline. COPD 2009; 6: 59–63.
- Hurst J.R, Vestbo J, Anzueto A et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128–38.
- Holguin F, Folch E, Redd S.C, Mannino D.M. Co - morbidity and mortality in COPD related hospitalisations in the United States 1979 to 2001. Chest 2005; 128: 2005–11.
- Wang P.S, Avorn J, Brookhart M.A et al. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension 2005; 46 (2): 273–9.
- Druss B.G, Marcus S.C, Olfson M, Pincus H.A. The most expensive medical conditions in America. Health Aff (Millwood) 2002; 21: 105–11.
- Чазова И.Е., Чучалин А.Г., Зыков К.А., Ратова Л.Г. Диагностика и лечение пациентов с артериальной гипертонией и хронической обструктивной болезнью легких (Рекомендации Российского медицинского общества по артериальной гипертонии и Российского респираторного общества). Системные гипертензии. 2013; 10 (1): 5–35.
- Bestall J.C, Paul E.A, Garrod R et al. Usefulness of the Medical Research Council (MRC) dyspnea scale as measure of dusability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581–6.
- Dodd J.W, Hogg L, Nolan J et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicenter, prospective study. Thorax 2011; 66: 425–9.
- Johannessen A, Nilsen R, Storeb M et al. Comparison of 2011 and 2007 gold guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med. Published on 05-April-2013 as 10.1164/rccm.201212-2276OC
- Lange P, Marott J.L, Vestbo J et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new gold classification: A study of the general population. Am J Respir Crit Care Med 2012; 186: 975–81.
- Soriano J.B, Alfageme I, Almagro P et al. Distribution and prognostic validity of the new gold grading classification. Chest 2012. E-published ahead of print 29 Nov 2012.
- Reda A.A, Kotz D, Kocks J.W et al. Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire. Respir Med 2010; 104: 1675–82.
- Agusti A, Hurd S, Jones P et al. Frequently asked questions about the gold 2011 assessment proposal of COPD. A comparative analysis of four different cohorts. ERJ Express. Published on May 3, 2013 as doi: 10.1183/09031936.00036513
- Miravitlles M, Soler-Cataluña J.J, Calle M et al. Spanish COPD guidelines (GesEPOC). Pharmacological treatment of stable COPD. Arch Bronconeumol 2012; 48: 247–57.